Criterion Capital Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.25M Hold
8,762
0.79% 37
2024
Q3
$1.25M Hold
8,762
0.79% 37
2024
Q2
$1.25M Hold
8,762
0.79% 37
2024
Q1
$1.13M Buy
8,762
+1,654
+23% +$197K 0.75% 36
2023
Q4
$735K Buy
+7,108
New +$703K 0.53% 41

Other funds holding NVO

Criterion Capital Advisors's NVO Position: Q4 2024 in Review

Criterion Capital Advisors held its Novo Nordisk (NVO) position steady in Q4 2024 at 8,762 shares worth $1.25M. The position accounts for 0.79% of the portfolio, ranked #37.

Criterion Capital Advisors first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Criterion Capital Advisors held 8,762 shares of Novo Nordisk worth $1.25M as of Q4 2024.
  • Criterion Capital Advisors left its Novo Nordisk share count unchanged in Q4 2024.
  • Novo Nordisk made up 0.79% of Criterion Capital Advisors's portfolio in Q4 2024, its #37 holding.
  • Criterion Capital Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.